Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.23.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 10,707 $ 8,219
Employee compensation and benefits 5,037 8,529
Professional fees 1,441 1,164
Facilities and other 143 54
Accrued expenses $ 17,328 $ 17,966